��������

Kevin Koh, PhD, is a prominent entrepreneur and leader in the medical technology and biotechnology sectors with extensive experience as Founder and CEO of Vivo Surgical Private Limited since April 2018, where notable achievements include the launch of the KLARO® surgical lighting device and securing exclusive technology licensing agreements. As a Member of the Governing Board at TÜV Rheinland Group and Chairman at PathoVax LLC, Kevin Koh actively contributes to the development of innovative healthcare solutions, including a universal HPV vaccine. Notable past roles include leadership positions at VerImmune, Metropolitan Festival Orchestra, and Vivo Diagnostics Pte Ltd, among others. Kevin Koh holds a PhD in Biomedical Engineering from Imperial College London and a BSc (Honours) in Molecular Cell Biology from UCL.